PhRMA
MARCH 6, 2025
Lawmakers on both sides of the aisle are renewing a multi-year effort to crack down on drug middlemen, known as pharmacy benefit managers (PBMs). These middlemen control what patients pay at the pharmacy counter, where they can get their medicine, what medicines they can get and what hoops they must jump through. The effort in Congress reflects mounting pressure to hold PBMs accountable and help lower patients’ out-of-pocket costs.
Big Molecule Watch
MARCH 6, 2025
On March 5, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed the District Court for the Northern District of West Virginias entry of a preliminary injunction preventing Celltrion, Inc. (Celltrion) from launching CT-P42, its aflibercept biosimilar of EYLEA. As we have previously reported , the Federal Circuit recently affirmed a similar preliminary injunction against Samsung and Formycon.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
MARCH 6, 2025
The M&A resurgence has been predicted for years, but the industry is still holding out, partly because the ideal range for biotech valuations has been harder to find.
Pharma Marketing Network
MARCH 6, 2025
Introduction Pharmaceutical marketing has evolved. Traditional advertising methods alone no longer cut it in todays digital-first world. Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. But heres the challenge: strict industry regulations make social media advertising tricky for pharma marketers.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharma Times
MARCH 6, 2025
Octapharma supports NHS in building resilient supply chain
pharmaphorum
MARCH 6, 2025
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Bryan Hill, life sciences chief technology officer at Cognizant, in a conversation on how generative AI is revolutionising life sciences and drug development.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
MARCH 6, 2025
NICE convenes third committee meeting for additional appraisal consideration
BioPharma Dive
MARCH 6, 2025
Optum, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in an interim decision while a formal review continues.
pharmaphorum
MARCH 6, 2025
Novo Nordisk has launched direct-to-consumer sales of its obesity drug Wegovy for uninsured or under-insured people at $499 per month.
Pharmaceutical Technology
MARCH 6, 2025
Tris Pharma previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Dive
MARCH 6, 2025
Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing medications, has a good shot at reaching market.
Pharmaceutical Technology
MARCH 6, 2025
FDA has granted approval for ARS Pharmaceuticals' neffy 1mg for treating anaphylaxis in paediatric patients.
pharmaphorum
MARCH 6, 2025
XRHealth has made its second acquisition in the space of a few months, buying digital therapeutics (DTx) company RealizedCare
Pharmaceutical Technology
MARCH 6, 2025
The company is planning an NDA submission for the neuroendocrine tumour-targeting ITM-11 later in 2025.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmaceutical Commerce
MARCH 6, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Pharmaceutical Technology
MARCH 6, 2025
While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.
Pharmaceutical Commerce
MARCH 6, 2025
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Tom Dorsett, CEO, RazorMetrics, shares the strategies that should be taken to overcome health information exchange blockages.
Pharmaceutical Technology
MARCH 6, 2025
TC BioPharm has signed a non-binding LoI to acquire a pharma company focused on commercialising intraocular pressure minimising therapies.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
pharmaphorum
MARCH 6, 2025
Days after NHS England CEO Amanda Pritchard resigned, national medical director Prof Sir Stephen Powis has also said he will also step down.
Pharmaceutical Technology
MARCH 6, 2025
Novo Nordisk increases efforts to rebuff pressures from the compounding marketplace.
BioPharma Dive
MARCH 6, 2025
Phase 3 studies for Amgen’s closely watched obesity drug were posted on a federal database. Elsewhere, Novo started up an online pharmacy and the FDA cleared testing of a base editing therapy for Duchenne.
Pharmaceutical Technology
MARCH 6, 2025
Trimtech Therapeutics has closed a seed funding round of $31m (25m) to advance its pipeline of CNS penetrant therapeutics.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmacy Times
MARCH 6, 2025
Policymakers and health care providers call for reforms to improve transparency, pricing, and patient access.
Pharmaceutical Technology
MARCH 6, 2025
With orphan drugs typically being high value, the potential risk of stock losses should be a top concern for biotechs looking to launch their products into new markets.
Pharmacy Times
MARCH 6, 2025
Elevidys offers significantly higher dystrophin production than existing Duchenne muscular dystrophy treatments but requires intensive monitoring for adverse events.
World Pharma News
MARCH 6, 2025
A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide - also known as Ozempic - in suppressing appetite and reducing body weight. Notably, testing in animals also showed that it worked without some of the drug's side effects such as nausea, constipation and significant loss of muscle mass. The newly discovered molecule, BRP, acts through a separate but similar metabolic pathway and activates different neurons in the brain - seemingly offering a
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MARCH 6, 2025
The approval is based on results from 2 phase 3 clinical trials that showed revakinagene taroretcels efficacy in macular telangiectasia type 2 (MacTel).
PharmaTech
MARCH 6, 2025
The alterations are the result of an agency review of findings from a clinical trial, and data from required postmarket studies.
PharmExec
MARCH 6, 2025
Joint venture is expected to leverage Astellas' expertise in cell therapy R&D and Yaskawas robotics technology to enhance accuracy, reproducibility, and efficiency in cell manufacturing.
Pharmaceutical Commerce
MARCH 6, 2025
The agreementpowered by YASKAWA's Maholo robotaims to address challenges in production and commercialization while offering access to academic and startup communities.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
70 
Let's personalize your content